Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of OBE001 in pregnant women with threatened preterm labour
2014-003217-28Phase 2Completed
- Sponsor
- ObsEva SA
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Preterm labor (PTL) comparing OBE001 arm with Placebo arm (2 arms). Primary endpoint: Incidence of women delivering within 7 days post first dose. Started Dec 2014; status: completed.
02
Drugs
nolasiban
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on 2014-003217-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003217-28.